e-Edition
Obituaries
Special Sections
Special Occasions
Contact

Subscribe
Paywall Login
Login to Comment
Register

December 11th, 2017

jobs

homes

Home
News
Sports
Business
Entertainment
Classifieds
Commentary

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Harmony Biosciences Holdings, Inc. - Common Stock (NQ:HRMY)

37.38 -0.04 (-0.11%)

Streaming Delayed Price Updated: 4:00 PM EST, Jan 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Harmony Biosciences Holdings, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Why Harsco Shares Surged Over 22%; Here Are 80 Biggest Movers From Yesterday ↗

November 02, 2022

Gainers

Via Benzinga

Where Harmony Biosciences Stands With Analysts ↗

October 14, 2022

Analysts have provided the following ratings for Harmony Biosciences (NASDAQ:HRMY) within the last quarter:

Via Benzinga

6 Analysts Have This to Say About Harmony Biosciences ↗

August 03, 2022

Harmony Biosciences (NASDAQ:HRMY) has observed the following analyst ratings within the last quarter:

Via Benzinga

Harmony Biosciences: Q1 Earnings Insights ↗

May 03, 2022

Harmony Biosciences (NASDAQ:HRMY) reported its Q1 earnings results on Tuesday, May 3, 2022 at 07:30 AM. Here's what investors need to know about the announcement.

Via Benzinga

Gartner, Sony, Uber And Other Big Gainers From Tuesday ↗

November 02, 2022

U.S. stocks closed lower on Tuesday, with the Nasdaq Composite dropping around 100 points. Here is the list of some big stocks recording gains in the previous session.

Via Benzinga

Harmony Biosciences Holdings, Inc. (HRMY) Q3 2022 Earnings Call Transcript ↗

November 01, 2022

HRMY earnings call for the period ending September 30, 2022.

Via The Motley Fool

Why IBD 50 Stock Harmony Biosciences Flew To The High End Of Its Buy Zone ↗

November 01, 2022

The third-quarter beat, alone, wasn't enough to drive the positive stock movement.

Via Investor's Business Daily

Recap: Harmony Biosciences Q3 Earnings ↗

November 01, 2022

Harmony Biosciences (NASDAQ:HRMY) reported its Q3 earnings results on Tuesday, November 1, 2022 at 07:30 AM. Here's what investors need to know about the announcement. Earnings Harmony Biosciences...

Via Benzinga

Harmony Biosciences Reports Third Quarter 2022 Financial Results and Business Updates

November 01, 2022

From Harmony Biosciences

Via GlobeNewswire

Benzinga's Top Ratings Upgrades, Downgrades For October 14, 2022 ↗

October 14, 2022

Upgrades

Via Benzinga

Domino's Pizza To Rally 20%? Here Are 5 Other Price Target Changes For Friday ↗

October 14, 2022

Wedbush raised Domino's Pizza, Inc. (NYSE: DPZ) price target from $370 to $400. Wedbush analyst Nick Setyan maintained an Outperform rating on the stock. Domino's shares rose 10.4% to close at $333.26...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 3, 2022 ↗

August 03, 2022

Via Benzinga

Stock Market Rally Mixed As Oil Prices Fall, Job Growth Hot: Weekly Review ↗

August 05, 2022

The Nasdaq and small caps rose while the S&P 500 is hitting resistance.

Via Investor's Business Daily

Harmony Biosciences Makes Leap Out Of Buy Zone After Narcolepsy Drug Drives Beat ↗

August 02, 2022

Shares surged well above the 5% chase zone in early action Tuesday.

Via Investor's Business Daily

Harmony Biosciences: Q2 Earnings Insights ↗

August 02, 2022

Harmony Biosciences (NASDAQ:HRMY) reported its Q2 earnings results on Tuesday, August 2, 2022 at 07:30 AM. Here's what investors need to know about the announcement.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

August 02, 2022

Via Benzinga

Preview: Harmony Biosciences's Earnings ↗

August 01, 2022

Harmony Biosciences (NASDAQ:HRMY) is set to give its latest quarterly earnings report on Tuesday, 2022-08-02. Here's what investors need to know before the announcement. Analysts estimate that Harmony...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 13, 2022 ↗

July 13, 2022

Upgrades

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 7, 2022 ↗

July 07, 2022

Upgrades

Via Benzinga

EXCLUSIVE: Has Biotech Bottomed? NYSE Executive Floor Director Says Biogen And These 3 Stocks Look Poised To Outperform ↗

June 30, 2022

Markets continue to trend lower amid rising inflation and Fed uncertainty, but one New York Stock Exchange floor director says the bottom may be in for a couple of beaten-down sectors.

Via Benzinga

Corcept Stock Near Buy Point; Strength Rating Jumps To 91 ↗

June 23, 2022

The new 91 RS Rating means that Corcept stock has outperformed 90% of all other stocks over the past year.

Via Investor's Business Daily

7 No-Brainer Biotech Stocks to Add to Your Buy List ↗

June 09, 2022

With the broader markets grumbling, investors should consider biotech stocks to buy for their permanently relevant profile.

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

May 03, 2022

Via Benzinga

Harmony Biosciences Q1 2022 Earnings Conference Call On May 3, 2022 At 08:30 AM ET ↗

April 21, 2022

Harmony Biosciences (NASDAQ:HRMY) will host a conference call at 08:30 AM ET on May 3, 2022, to discuss Q1 2022 earnings results.

Via Benzinga

80 Biggest Movers From Yesterday ↗

May 04, 2022

Gainers Blue Water Vaccines, Inc. (NASDAQ: BWV) shares jumped 93.1% to close at $6.45 on Tuesday on above-average volume. XORTX Therapeutics Inc. (NASDAQ: XRTX) gained 59.1% to...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For April 14, 2022 ↗

April 14, 2022

Upgrades

Via Benzinga

24 Biggest Movers From Yesterday ↗

April 13, 2022

Gainers Vertical Aerospace Ltd. (NYSE: EVTL) Shares hiked 30.93% to close at $9.82 on Tuesday after Deutsche Bank initiated coverage of the stock. Peabody Energy Corporation (...

Via Benzinga

Bristol Myers, Eli Lilly And 2 Others Prove You Can Still Make Money In Medical Stocks ↗

March 11, 2022

These four medical stocks are outperforming the lousy market for health care investors.

Via Investor's Business Daily

Harmony Biosciences: Q4 Earnings Insights ↗

February 28, 2022

Harmony Biosciences (NASDAQ:HRMY) reported its Q4 earnings results on Monday, February 28, 2022 at 07:30 AM. Here's what investors need to know about the announcement....

Via Benzinga

3 Desirable Drug Stocks With Very Promising Pipelines ↗

February 16, 2022

Drug makers with superb pipelines are likely to deliver great returns for long-term investors. Here are three drug stocks to consider.

Via InvestorPlace

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

More ways to get to us

Facebook

Twitter

YouTube

ePaper Login
Subscribe
Subscription Services
Archive

About Us

The Lethbridge Herald
Other Publications
Food For Thought

Contact
Careers

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

Advertising
Terms and Conditions & Privacy Policy